Drugs and Devices

FDA approves first generic capecitabine to treat breast and colorectal cancers

On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and colorectal cancer. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares